China's Innovent signs $11.4 billion cancer therapy deal with Japan's Takeda – Reuters

Written by

admin

in

  1. China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda  Reuters
  2. Takeda Inks Deal With China’s Innovent to Develop Cancer Drugs  Bloomberg
  3. Innovent Biologics Sells License to Two Cancer Drugs to Takeda; Shares Up 3%  MarketScreener
  4. Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors  Business Wire
  5. Innovent Biologics Partners with Takeda for Global Cancer Therapy Development  TipRanks

Continue Reading

More posts